SCR-LIP-000508 · Claim · machine-readable JSON →

In a systematic review of 16 studies covering 4537 lipedema patients, reported depression prevalence ranged from 23% to 59.2% (40% in the largest study, n=1362), with mean PHQ-9 scores of 10.8-12.2 (mild-to-moderate depression) and a suggested dose-response association with lipedema stage.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2025Lipedema and depression - A systematic review (2025) · consistent

Evidence (1)

Context (PECO)

Populationpatients with lipedema (4537 across 16 studies)
Conditionlipedema
Exposurelipedema diagnosis
Comparatorgeneral population and obese patients
Outcomedepression prevalence and severity (PHQ-9)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log